Tsyganov, M.M.; Sorokovikova, S.S.; Lutzkaya, E.A.; Ibragimova, M.K.
Mutations of BRCA1, BRCA2, and PALB2 Genes in Breast Tumor Tissue: Relationship with the Effectiveness of Neoadjuvant Chemotherapy and Disease Prognosis. Genes 2023, 14, 1554.
https://doi.org/10.3390/genes14081554
AMA Style
Tsyganov MM, Sorokovikova SS, Lutzkaya EA, Ibragimova MK.
Mutations of BRCA1, BRCA2, and PALB2 Genes in Breast Tumor Tissue: Relationship with the Effectiveness of Neoadjuvant Chemotherapy and Disease Prognosis. Genes. 2023; 14(8):1554.
https://doi.org/10.3390/genes14081554
Chicago/Turabian Style
Tsyganov, Matvey M., Sofia S. Sorokovikova, Elizaveta A. Lutzkaya, and Marina K. Ibragimova.
2023. "Mutations of BRCA1, BRCA2, and PALB2 Genes in Breast Tumor Tissue: Relationship with the Effectiveness of Neoadjuvant Chemotherapy and Disease Prognosis" Genes 14, no. 8: 1554.
https://doi.org/10.3390/genes14081554
APA Style
Tsyganov, M. M., Sorokovikova, S. S., Lutzkaya, E. A., & Ibragimova, M. K.
(2023). Mutations of BRCA1, BRCA2, and PALB2 Genes in Breast Tumor Tissue: Relationship with the Effectiveness of Neoadjuvant Chemotherapy and Disease Prognosis. Genes, 14(8), 1554.
https://doi.org/10.3390/genes14081554